Blueprint Medicines Corp (BPMC)
80.73 x 1 120.00 x 1
Post-market by (Cboe BZX)
89.58 -0.26 (-0.29%) 03/14/25 [NASDAQ]
80.73 x 1 120.00 x 1
Post-market 89.58 unch (unch) 16:03 ET
for Fri, Mar 14th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 146,367 | 128,184 | 138,157 | 96,116 | 71,957 |
| Cost of Goods | 7,447 | 1,932 | 7,593 | 3,191 | 215 |
| Gross Profit | 138,920 | 126,252 | 130,564 | 92,925 | 71,742 |
| Operating Expenses | 180,569 | 176,158 | 174,202 | 171,939 | 177,066 |
| Operating Income | -41,202 | -48,974 | -43,045 | -78,823 | -105,109 |
| Interest Expense | 7,776 | 7,616 | 6,864 | 5,895 | 5,170 |
| Other Income | -306 | 587 | 17 | 174,034 | -578 |
| Pre-tax Income | -49,284 | -56,003 | -49,892 | 89,316 | -110,857 |
| Income Tax | 671 | 273 | 102 | 180 | 61 |
| Net Income Continuous | -49,955 | -56,276 | -49,994 | 89,136 | -110,918 |
| Net Income | $-49,955 | $-56,276 | $-49,994 | $89,136 | $-110,918 |
| EPS Basic Total Ops | -0.83 | -0.89 | -0.80 | 1.45 | -1.83 |
| EPS Basic Continuous Ops | -0.83 | -0.89 | -0.80 | 1.45 | -1.82 |
| EPS Diluted Total Ops | -0.78 | -0.89 | -0.80 | 1.40 | -1.83 |
| EPS Diluted Continuous Ops | -0.78 | -0.89 | -0.80 | 1.40 | -1.82 |
| EPS Diluted Before Non-Recurring Items | -0.79 | -0.89 | -0.80 | -1.32 | -1.82 |
| EBITDA(a) | $-42,494 | $-51,445 | $-45,073 | $-79,206 | $-109,517 |